Form 8.3 - Dechra Pharmaceuticals plc

RNS Number : 8340X

Barclays PLC

22 December 2023

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				DECHRA PHARMACEUTICALS PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				21 Dec 2023
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				1p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			7,984,072	7.01%	2,567,694	2.25%
(2)	Cash-settled derivatives:
	and/or controlled:			854,911	0.75%	7,914,081	6.95%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			8,838,983	7.76%	10,481,775	9.20%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
1p ordinary		Purchase		19,215		38.4172 GBP
1p ordinary		Purchase		16,800		38.4200 GBP
1p ordinary		Purchase		9,654		38.4146 GBP
1p ordinary		Purchase		5,427		38.4180 GBP
1p ordinary		Purchase		1,135		38.4197 GBP
1p ordinary		Purchase		787		38.3875 GBP
1p ordinary		Purchase		480		38.4400 GBP
1p ordinary		Purchase		453		38.4000 GBP
1p ordinary		Purchase		431		38.4011 GBP
1p ordinary		Purchase		349		38.4100 GBP
1p ordinary		Purchase		293		38.3754 GBP
1p ordinary		Purchase		2		38.4150 GBP
1p ordinary		Sale		32,950		38.4000 GBP
1p ordinary		Sale		20,955		38.4200 GBP
1p ordinary		Sale		7,036		38.3795 GBP
1p ordinary		Sale		5,768		38.3924 GBP
1p ordinary		Sale		4,084		38.4169 GBP
1p ordinary		Sale		414		38.4351 GBP
1p ordinary		Sale		195		38.4192 GBP
1p ordinary		Sale		160		38.4054 GBP
1p ordinary		Sale		71		38.4285 GBP
1p ordinary		Sale		65		38.3982 GBP
1p ordinary		Sale		20		38.4400 GBP
1p ordinary		Sale		12		38.4161 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
1p ordinary		SWAP		Decreasing Long		24	38.4133 GBP
1p ordinary		SWAP		Decreasing Long		1,160	38.4200 GBP
1p ordinary		SWAP		Decreasing Long		8,177	38.4208 GBP
1p ordinary		SWAP		Decreasing Short		13	38.4161 GBP
1p ordinary		CFD		Decreasing Short		65	38.3983 GBP
1p ordinary		SWAP		Decreasing Short		414	38.4351 GBP
1p ordinary		CFD		Decreasing Short		5,612	38.3974 GBP
1p ordinary		SWAP		Decreasing Short		8,131	38.3751 GBP
1p ordinary		SWAP		Decreasing Short		31,816	38.4000 GBP
1p ordinary		SWAP		Increasing Long		56	38.4000 GBP
1p ordinary		SWAP		Increasing Short		2	38.4138 GBP
1p ordinary		SWAP		Increasing Short		20	38.4150 GBP
1p ordinary		CFD		Increasing Short		382	38.4200 GBP
1p ordinary		SWAP		Increasing Short		610	38.3715 GBP
1p ordinary		SWAP		Increasing Short		1,738	38.4200 GBP
1p ordinary		SWAP		Increasing Short		2,988	38.4099 GBP
1p ordinary		SWAP		Increasing Short		5,576	38.4141 GBP
1p ordinary		SWAP		Increasing Short		9,654	38.4146 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				22 Dec 2023
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETEALAAAFFDFFA